4-Hydroxybenzomorphane
European patent · EP2251330 · Deleted
Register entry
- Publication number
- EP2251330
- Application number
- EP10008474
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Nov 3, 2005
- Published
- Nov 17, 2010
- Granted
- May 9, 2012
- Deleted
- Nov 3, 2025
- Reason
- Maximum term reached
- IPC classes
- C07D 221/26 (2006.01)A61K 31/485 (2006.01)C07D 221/28 (2006.01)
- Priority
- US 625348 P 05.11.2004
- Divided from
- EP05851351
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Nov 3, 2025
Maximum term reached
- Status of protective title
- Active → Cancelled
- Cancellation date
- 03.11.2025
- Cause for cancellation
- Expiry of maximum term of protection
Published in Swissreg on 03.11.2025
- Dec 1, 2024
Change
Published in Swissreg on 01.12.2024
- Dec 1, 2023
Change
Published in Swissreg on 01.12.2023
- Oct 10, 2023
Address changed
- Representative
- Patentanwaltskanzlei Nückel, Oberdorfstrasse 16, 8820 Wädenswil → Patentanwaltskanzlei Nückel, Eichweidstrasse 22, 8820 Wädenswil
Published in Swissreg on 10.10.2023
- Dec 6, 2022
Change
Published in Swissreg on 06.12.2022
- Feb 2, 2018
Address changed
- Representative
- Patentanwaltskanzlei Nückel, Weinberglistrasse 4, 6005 Luzern → Patentanwaltskanzlei Nückel, Oberdorfstrasse 16, 8820 Wädenswil
Published in Swissreg on 02.02.2018
- Aug 21, 2012
Agent entered
- Representative
- Patentanwaltskanzlei Nückel, Weinberglistrasse 4, 6005 Luzern
Published in Swissreg on 21.08.2012
- May 9, 2012
Granted
Published in Swissreg on 09.05.2012
Parties
Inventor
Wentland, Mark P.
Menands, New York 12204, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.